The analytical lab model needs an upgrade to serve the medical cannabis industry, writes QNTM founders Justin Ihnken and Connor Murphy and Agilent's Anthony Macherone.
Analytical Cannabis caught up with Paulson to learn more about his lab's recent study of hemp-derived THC products.
Writing in the Conversation, Benjamin Land, a research associate professor of pharmacology at the University of Washington, explains how cannabis could be used as an opioid substitute.
Chris Hudalla, president and chief scientific officer at ProVerde Laboratories, explores the legality and implications of novel synthetic cannabinoids.
Joe Humphreys, business development manager at Eurofins Food & Water Testing, discusses the journey of CBD testing.
Genetec's Scott Thomas outlines the three security factors every entrepreneur should consider before opening their cannabis production facility.
Analytical Cannabis recently caught up with the minds behind Cannatrol to learn more about cannabis drying and the company's innovative approach to curing.
Heavy metals expert Robert Thomas explores how stainless steel equipment could pose a contamination risk in cannabis operations.
Morgan Keefer, an accreditation officer at A2LA, explains exactly why cannabis testing labs need ISO accreditation.